This technology is a neural network architecture that quantifies in vivo metabolites from magnetic resonance spectroscopy for improved disease detection and diagnosis.
This technology is a self-administered version of the ALS Functional Rating Scale-Revised (ALSFRS-R) that enables patients to reliably assess their functional status remotely for clinical monitoring and research applications.
